APRIL CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Phase I Clinical Trial

被引：0
|
作者：
Li, Wenxiao [1 ,2 ,3 ,4 ]
Hu, Yongxian [1 ,2 ,4 ,5 ]
Zhang, Mingming [1 ,2 ,4 ,5 ]
Lai, Xinyi [1 ,2 ,4 ,5 ]
Zhao, Mengyu [1 ,2 ,4 ,5 ]
Fu, Shan [1 ,2 ,4 ,5 ]
Hong, Ruimin [1 ,2 ,4 ,5 ]
Chang, Alex H. [6 ]
Huang, He [1 ,2 ,4 ,7 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Sch Med, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sch Med, Liangzhu Lab, Hangzhou, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China
[4] Zhejiang Univ, Inst Hematol, Hangzhou, Peoples R China
[5] Zhejiang Prov Engn Res Ctr Stem Cell & Immun Thera, Hangzhou, Peoples R China
[6] Shanghai Yake Biotechnol Co Ltd, Shanghai, Peoples R China
[7] Zhejiang Prov Engn Res Ctr Stem Cell & Immun Thera, Hangzhou, Peoples R China
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-209660
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7229 / 7229
页数：1
相关论文
共 50 条
  • [31] Phase I Study of BCMA CAR-T using instant manufacturing platform or traditional production process for relapsed/refractory multiple myeloma therapy
    Liu, Hui
    Wang, Ting
    Yang, Yazi
    Feng, Ru
    Li, Jiangtao
    Zhang, Chunli
    Bai, Jiefei
    Ding, Yanping
    Liu, Guanghua
    Wu, Fei
    Lu, Xinan
    He, Ting
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S5 - S5
  • [32] Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
    He, Shao-long
    Cheng, Yu-hang
    Wang, Di
    Xu, Meng-lei
    Que, Yi-mei
    Xu, Yan-jie
    Ma, Liang-ming
    Li, Chun-rui
    Zhou, Jian-feng
    CURRENT MEDICAL SCIENCE, 2021, 41 (03) : 474 - 481
  • [33] A suggestion to improve the results of "Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma"
    Arash, Majid
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [34] Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
    Shao-long He
    Yu-hang Cheng
    Di Wang
    Meng-lei Xu
    Yi-mei Que
    Yan-jie Xu
    Liang-ming Ma
    Chun-rui Li
    Jian-feng Zhou
    Current Medical Science, 2021, 41 : 474 - 481
  • [35] Overview of anti-BCMA CAR-T immunotherapy for multiple myeloma and relapsed/refractory multiple myeloma
    Feng, Deming
    Sun, Jian
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 92 (02)
  • [36] Efficacy and Safety of CAR-T Therapy with Safety Switch Targeting Bcma for Patients with Relapsed/Refractory Multiple Myeloma in a Phase 1 Clinical Study
    Fu, Weijun, Sr.
    Du, Juan
    Jiang, Hua
    Cheng, Zhi
    Wei, Runhong
    Yu, Kang
    Jiang, Songfu
    He, Feng
    Fang, Hongliang
    Liu, Yarong
    Wang, Pin
    BLOOD, 2019, 134
  • [37] A new CAR-T cell therapy for multiple myeloma
    Hosen, Naoki
    CANCER SCIENCE, 2022, 113 : 644 - 644
  • [38] Cost per Responder Analysis to Assess the Value of CAR-T Therapy for Relapsed or Refractory Multiple Myeloma
    Martin, Thomas
    Usmani, Saad Z.
    Joseph, Nedra
    Crivera, Concetta
    Valluri, Satish
    Jackson, Carolyn C.
    Cohen, Lucas
    Singh, Sumeet
    Jagannath, Sundar
    BLOOD, 2021, 138
  • [39] BCMA CAR-T therapy combined with pomalidomide is a safe and effective treatment for relapsed/refractory multiple myeloma
    Yan, Yuhan
    Tu, Yixuan
    Cheng, Qian
    Zhang, Jian
    Wang, Erhua
    Deng, Zuqun
    Yu, Yan
    Wang, Liwen
    Liu, Rui
    Chu, Ling
    Kang, Liqing
    Liu, Jing
    Li, Xin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [40] A Phase 2 Study of Nivolumab for Relapsed/Refractory Multiple Myeloma or Non-Hodgkin Lymphoma Following CAR-T Therapy
    Banerjee, Rahul
    Lynch, Ryan C.
    Wu, Qian
    Simon, Sylvain
    Ujjani, Chaitra S.
    Till, Brian G.
    Wuliji, Natalie
    Gausman, Daria
    Dizon, Joshua
    Kwok, Mary L.
    Lee, Sarah S.
    Silbermann, Rebecca
    Medvedova, Eva
    Maloney, David G.
    Ramos, Jorge Daniel
    Shadman, Mazyar
    Gauthier, Jordan
    Turtle, Cameron J.
    Gopal, Ajay K.
    Green, Damian J.
    Riddell, Stanley R.
    Cowan, Andrew J.
    BLOOD, 2023, 142
12345